COmprehensiVE assessment of peRcutaneous implanted pulmonary valve prostheses to determine the incidence of *HALT*. An exploratory study.

Recruiting

• Conditions: PPVI endocarditis; infection of endocardium/heart valves; 10082206

• Registration Number: NL-OMON54990
• Lead Sponsor: Erasmus MC, Universitair Medisch Centrum Rotterdam

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Last Update Posted: 15 April 2024

Recruitment & Eligibility

• Status: Recruiting
• Sex: Not specified
• Target Recruitment: 60

Inclusion Criteria

- Underwent PPVI
- Age > 18 years

Exclusion Criteria

- Pregnancy
- Unwillingness to sign informed consent
- Known allergy to iodinated contrast material
- Indication to perform prehydration prior to intravenous contrast material
admin-istration according to the guidelines in the EMC
- Unwillingness to be informed about unrequested findings on the CT

Study & Design

• Study Type: Observational invasive
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<p>Incidence of HALT as detected by computed tomography CT on percutaneously<br /><br>implanted pulmonary prosthetic heart valves. </p><br>

Secondary Outcome Measures

Name	Time	Method
<p>Secondary, the relation of blood biomarkers and MRI flow profiles to HALT.<br /><br>Incidence of HALT on TTE.</p><br>